#Spotlight: India is set to get a generic version of the viral diabetes drug Ozempic, as Dr Reddy’s Laboratories receives regulatory approval to manufacture and sell the medication. The Indian drugmaker plans to roll out 12 million semaglutide injection pens in the first year. Originally developed by Denmark-based Novo Nordisk, Ozempic is now included in the World Health Organisation’s Model List of Essential Medicines. Beyond diabetes control, Ozempic has gone viral globally for its off-label u